Nuveen’s Boundless Bio BOLD Stock Holding History

Nuveen’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,958,413	Closed	-$399M	–	3440
2025 Q1	$399M	Buy	3,958,413 +3,936,890	+18,292%	+$8.16M	0.12%	156
2024 Q4	$62.4K	Buy	+21,523	New	+$62.7K	﹤0.01%	3311

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's BOLD Position: Q2 2025 in Review

Nuveen sold out of Boundless Bio (BOLD) in Q2 2025, closing a stake of 3,958,413 shares — an estimated $399M sold.

Nuveen first reported a position in BOLD in Q4 2024 and held it in 2 quarters. The position peaked at $399M in Q1 2025. 44 funds tracked by Wall St. Rank hold BOLD as of Q2 2025.

Nuveen reported no remaining Boundless Bio position as of Q2 2025 after selling out during the quarter.
Nuveen sold 3,958,413 Boundless Bio shares in Q2 2025, an estimated $399M.
Nuveen first reported a position in Boundless Bio in Q4 2024 and held it in 2 quarters.
Nuveen's Boundless Bio position peaked at $399M in Q1 2025.
44 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.